Transplant Experts Debate Ethical Age Limits as Study Shows Older Lung Recipients Achieve Survival Comparable to Youth

Specialists at ISHLT 2026 debate age limits as new data shows patients over 70 can achieve lung transplant survival rates comparable to much younger patients.

By: AXL Media

Published: Apr 22, 2026, 4:16 AM EDT

Source: Information for this report was sourced from International Society for Heart and Lung Transplantation

The Evolving Standard of Transplant Candidacy

During the International Society for Heart and Lung Transplantation (ISHLT) annual meeting in Toronto, medical leaders addressed the ethically complex question of age limits for lung transplantation. While being over 65 was considered a disqualifying factor until 2014, current 2021 ISHLT guidelines have extended the recommended age limit to 70. Dr. Brian Keller, Medical Director of Lung Transplantation at Massachusetts General Hospital, noted that an aging population and advancements in medical therapies are resulting in an increasing number of candidates in their mid-to-late 60s and 70s. This shift has forced the medical community to re-examine how donor organs are allocated in an environment of extreme scarcity.

Ethical Tension Between Utility and Justice

The debate over age is fundamentally a conflict between two primary ethical principles: utility and justice. Dr. Keller explained that the dilemma rests on whether donor lungs should prioritize younger patients, who may contribute longer to the workforce and have higher long-term survival, or older patients who have already contributed to society. This tension is exacerbated by a severe shortage of organs; in 2023 alone, the adult lung transplant waiting list grew by over 37% compared to the previous decade. While older recipients face higher risks of cardiovascular disease and cancer due to immunosuppression, many argue that age alone is an insufficient metric for determining who deserves a life-saving procedure.

Chronological Versus Biological Assessment

Dr. Thomas Egan, a professor of surgery at the University of North Carolina and a pioneer in the field, argued that arbitrary age cutoffs fail to account for biological variability. He observed that a 75-year-old may possess the biological vitality of a 60-year-old, while some younger patients may present with comorbidities that make them poor candidates for surgery. Dr. Egan advocated for an individualized assessment process, suggesting that disqualifying individuals based solely on a birth date ignores the nuances of physical fitness and the specific capacity of a patient to benefit from a transplant.